Table of Content

1 Market
1.1 Product Definition
1.1.1 Inclusion and Exclusion
1.1.2 Key Questions Answered in the Report

2 Research Methodology
2.1 Global Single Cell Bioinformatics Software and Services Market: Research Methodology
2.2 Data Sources
2.2.1 Primary Data Sources
2.2.2 Secondary Data Sources
2.3 Market Estimation Model
2.4 Criteria for Company Profiling

3 Market Overview
3.1 Overview
3.1.1 Market Footprint and Growth Potential, $Million, 2020-2031
3.1.2 Future Potential
3.1.3 COVID-19 Impact on Market

4 Industry Insights
4.1 Patent Analysis
4.1.1 Patent Filing Trend
4.1.2 Patent Analysis (by Year)
4.1.3 Patent Analysis (by Region)
4.1.4 Patent Analysis (by Country)

5 Competitive Landscape
5.1 Competitive Landscape
5.1.1 Acquisitions
5.1.2 Synergistic Activities
5.1.3 Product Launches and Upgradations
5.1.4 Business Expansion
5.1.5 Fundings
5.1.6 Market Share Analysis (2019-2020)
5.1.7 Growth-Share Analysis (2019-2020)
5.1.7.1 Growth-Share Analysis by Application
5.1.7.2 Growth-Share Analysis by End-user

6 Market Dynamics
6.1 Overview
6.2 Impact Analysis
6.3 Market Drivers
6.3.1 Rapid Development in the Single Cell Technologies
6.3.2 Advancing Field of Disease Diagnosis and Drug Discovery
6.3.3 Investments by the Biopharmaceutical Companies
6.4 Market Restraints
6.4.1 Barriers to Carry Out Effective Single Cell Analysis
6.4.2 Analytical Challenges in Metabolite Analysis
6.4.3 Lack of Spatial-Temporal Context
6.5 Market Opportunities
6.5.1 Rising Number of Multi-Omics Approach in Single Cell Sequencing
6.5.2 Role of Spatial Transcriptomics in Single Cell Sequencing

7 Global Single Cell Bioinformatics Software and Services Market, by Product, $Million, 2020 - 2031
7.1 Overview
7.2 Bioinformatic Software
7.3 Bioinformatic Services
7.3.1 Genomics Analysis
7.3.2 Transcriptome Analysis
7.3.3 Metabolomics Analysis
7.3.4 Epigenomics Analysis
7.3.5 Proteomic Analysis
7.3.6 Others

8 Global Single Cell Bioinformatics Software and Services Market, by Application, $Million, 2020 - 2031
8.1 Overview
8.2 Oncology
8.3 Immunology
8.4 Neurology
8.5 Non-invasive Prenatal Diagnosis (NIPD)
8.6 Microbiology
8.7 Others

9 Global Single cell bioinformatics software and services Market, by End-User, $Million, 2020 - 2031
9.1 Overview
9.2 Biopharmaceutical Companies
9.3 Research and Academic Institutes
9.4 Others

10 Global Single Cell Bioinformatics Software and Services Market, by Region, $Million, 2020-2031
10.1 Overview
10.2 North America
10.2.1 North America Single Cell Bioinformatics Software and Services Market (by Application)
10.2.2 U.S.
10.2.3 Canada
10.3 Europe
10.3.1 Europe Single Cell Bioinformatics Software and Services Market (by Application)
10.3.2 Germany
10.3.3 France
10.3.4 U.K.
10.3.5 Italy
10.3.6 Spain
10.3.7 Rest-of-Europe
10.4 Asia-Pacific
10.4.1 Asia-Pacific Single Cell Bioinformatics Software and Services Market (by Application)
10.4.2 Japan
10.4.3 China
10.4.4 Australia
10.4.5 India
10.4.6 South Korea
10.4.7 Rest-of-Asia-Pacific
10.5 Latin America
10.5.1 Latin America Single Cell Bioinformatics Software and Services Market (by Application)
10.5.2 Brazil
10.5.3 Mexico
10.5.4 Rest-of-Latin America
10.6 Rest-of-the-World
10.6.1 Rest-of-the-World Single Cell Bioinformatics Software and Services Market (by Application)

11 Company Profiles
11.1 Overview
11.2 Market Value Chain of Single Cell Bioinformatics Software and Services
11.3 Illumina, Inc.
11.3.1 Company Overview
11.3.2 Role of Illumina, Inc. in the Global Single Cell Bioinformatics Software and Services Market
11.3.3 Key Customers of the Company
11.3.4 Key Competitors of the Company
11.3.5 Financials
11.3.6 Key Insights About Financial Health of the Company
11.3.7 SWOT Analysis
11.4 QIAGEN N.V.
11.4.1 Company Overview
11.4.2 Role of QIAGEN N.V. in the Global Single Cell Bioinformatics Software and Services Market
11.4.3 Key Customers of the Company
11.4.4 Key Competitors of the Company
11.4.5 Financials
11.4.6 Key Insights About Financial Health of the Company
11.4.7 SWOT Analysis
11.5 BD.
11.5.1 Company Overview
11.5.2 Role of BD. in the Global Single Cell Bioinformatics Software and Services Market
11.5.3 Key Competitors of the Company
11.5.4 Financials
11.5.5 Key Insights About Financial Health of the Company
11.5.6 SWOT Analysis
11.6 PacBio
11.6.1 Company Overview
11.6.2 Role of PacBio in the Global Single Cell Bioinformatics Software and Services Market
11.6.3 Key Customers of the Company
11.6.4 Key Competitors of the Company
11.6.5 Financials
11.6.6 Key Insights About Financial Health of the Company
11.6.7 SWOT Analysis
11.7 Fluidigm Corporation
11.7.1 Company Overview
11.7.2 Role of Fluidigm Corporation in the Global Single Cell Bioinformatics Software and Services Market
11.7.3 Key Customers of the Company
11.7.4 Key Competitors of the Company
11.7.5 Financials
11.7.6 Key Insights About Financial Health of the Company
11.7.7 SWOT Analysis
11.8 NanoString
11.8.1 Company Overview
11.8.2 Role of NanoString in the Global Single Cell Bioinformatics Software and Services Market
11.8.3 Key Customers of the Company
11.8.4 Key Competitors of the Company
11.8.5 Financials
11.8.6 Key Insights About Financial Health of the Company
11.8.7 SWOT Analysis
11.9 Takara Bio Inc.
11.9.1 Company Overview
11.9.2 Role of Takara Bio Inc. in the Global Single Cell Bioinformatics Software and Services Market
11.9.3 Key Customers of the Company
11.9.4 Key Competitors of the Company
11.9.5 Financials
11.9.6 Key Insights About Financial Health of the Company
11.9.7 SWOT Analysis
11.1 BGI
11.10.1 Company Overview
11.10.2 Role of BGI in the Global Single Cell Bioinformatics Software and Services Market
11.10.3 Key Competitors of the Company
11.10.4 SWOT Analysis
11.11 Oxford Nanopore Technologies plc.
11.11.1 Company Overview
11.11.2 Role of Oxford Nanopore Technologies plc. in the Global Single Cell Bioinformatics Software and Services Market
11.11.3 Key Competitors of the Company
11.11.4 Financials
11.11.5 Key Insights About Financial Health of the Company
11.11.6 SWOT Analysis
11.12 Partek, Incorporated
11.12.1 Company Overview
11.12.2 Role of Partek, Incorporated in the Global Single Cell Bioinformatics Software and Services Market
11.12.3 SWOT Analysis
11.13 Akoya Biosciences, Inc.
11.13.1 Company Overview
11.13.2 Role of Akoya Biosciences, Inc. in the Global Single Cell Bioinformatics Software and Services Market
11.13.3 Key Customers of the Company
11.13.4 SWOT Analysis
11.14 IsoPlexis
11.14.1 Company Overview
11.14.2 Role of IsoPlexis in the Global Single Cell Bioinformatics Software and Services Market
11.14.3 Key Customers of the Company
11.14.4 SWOT Analysis
11.15 Scipio Bioscience
11.15.1 Company Overview
11.15.2 Role of Scipio Biosciences in the Global Single Cell Bioinformatics Software and Services Market
11.15.3 Key Customers of the Company
11.16 Scailyte
11.16.1 Company Overview
11.16.2 Role of Scailyte in the Global Single Cell Bioinformatics Software and Services Market
11.17 BioBam Spain
11.17.1 Company Overview
11.17.2 Role of BioBam Spain in the Global Single Cell Bioinformatics Software and Services Market
11.17.3 Key Customers of the Company
11.18 Emerging Companies
11.18.1 Singleron Biotechnologies
11.18.2 Mission Bio
11.18.3 Dolomite Bio
11.18.4 Menarini Silicon Biosystems
11.18.5 Elucidata
List of Figures
Figure 1: Global Incidence of Cancer in Millions, 2014-2019
Figure 2: Impact Analysis of Market Drivers and Market Challenges on the Global Single Cell Bioinformatics Software and Services Market
Figure 3: Global Single Cell Bioinformatics Software and Services Market (by Product), $Million, 2020 and 2031
Figure 4: Global Single Cell Bioinformatics Software and Services Market (by Application), $Million, 2020 and 2031
Figure 5: Global Single Cell Bioinformatics Software and Services Market (by End-User), $Million, 2020 and 2031
Figure 6: Global Single Cell Bioinformatics Software and Services Market Snapshot (by Region)
Figure 7: Global Single Cell Bioinformatics Software and Services Market Segmentation
Figure 8: Global Single Cell Software and Services Market: Research Methodology
Figure 9: Primary Research Methodology
Figure 10: Bottom-Up Approach (Segment-Wise Analysis)
Figure 11: Top-Down Approach (Segment-Wise Analysis)
Figure 12: Global Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 13: Company Collaborations During COVID-19 (2020-2022)
Figure 14: Year-Wise Analysis of Patents Related to Single Cell Bioinformatics, January 2019-January 2022
Figure 15: Region-Wise Analysis of Patents Related to Single Cell Bioinformatics, January 2018-January 2022
Figure 16: Country-Wise Analysis of Patents Related to Single Cell Bioinformatics, January 2018-January 2022
Figure 17: Share of Key Developments and Strategies, January 2019-March 2022
Figure 18: Share of Acquisitions (by Company), January 2018-January 2021
Figure 19: Synergistic Activities Share (by Company), January 2018-March 2022
Figure 20: Product Launches and Upgradations (by Company), January 2018–March 2022
Figure 21: Share of Business Expansion Activities (by Company), January 2018-March 2022
Figure 22: Market Share Analysis for Global Single Cell Bioinformatics Software and Services Market, $Million, 2019 and 2020
Figure 23: Growth-Share Analysis of Global Single Cell Bioinformatics Software and Services Market (by Application), 2020-2031
Figure 24: Growth-Share Matrix for Global Single Cell Bioinformatics Software and Services Market (by End-user), 2020
Figure 25: Increasing Number of Single-Cell Bioinformatic Product Launches Over the Years (2017-2021)
Figure 26: Increasing Number of Publications with “Single Cell” Keyword Over the Years (2010-2021)
Figure 27: Total Single-Cell Multi-Omics Publications over the Years (2011-2021)
Figure 28: Total Single-Cell Spatial Transcriptomics Publications over the Years (2011-2021)
Figure 29: Global Single Cell Bioinformatics Software and Services Market (by Product)
Figure 30: Global Single Cell Bioinformatics Software and Services Market (by Product), $Million, 2020 and 2031
Figure 31: Global Single Cell Bioinformatics Software and Services Market (Bioinformatics Software), $Million, 2020-2031
Figure 32: Global Single Cell Bioinformatics Software and Services Market (Bioinformatics Services), $Million, 2020-2031
Figure 33: Global Single Cell Bioinformatics Software and Services Market (Genomics Analysis), $Million, 2020-2031
Figure 34: Single Cell Transcriptome Analysis of Tissues and Cell Types
Figure 35: Global Single Cell Bioinformatics Software and Services Market (Transcriptome Analysis), $Million, 2020-2031
Figure 36: Global Single Cell Bioinformatics Software and Services Market (Metabolomic Analysis), $Million, 2020-2031
Figure 37: Global Single Cell Bioinformatics Software and Services Market (Epigenomic Analysis), $Million, 2020-2031
Figure 38: Global Single Cell Bioinformatics Software and Services Market (Proteomic Analysis), $Million, 2020-2031
Figure 39: Global Single Cell Bioinformatics Software and Services Market (Other), $Million, 2020-2031
Figure 40: Global Single Cell Bioinformatics Software and Services Market (by Application)
Figure 41: Global Single Cell Bioinformatics Software and Services Market (by Application), $Million, 2020 and 2031
Figure 42: Global Single Cell Bioinformatics Software and Services Market (Oncology), $Million, 2020-2031
Figure 43: Global Single Cell Bioinformatics Software and Services Market (Immunology), $Million, 2020-2031
Figure 44: Global Single Cell Bioinformatics Software and Services Market (Neurology), $Million, 2020-2031
Figure 45: Global Single Cell Bioinformatics Software and Services Market (Non-invasive Prenatal Diagnosis), $Million, 2020-2031
Figure 46: Global Single Cell Bioinformatics Software and Services Market (Microbiology), $Million, 2020-2031
Figure 47: Global Single Cell Bioinformatics Software and Services Market (Others), $Million, 2020-2031
Figure 48: Global Single Cell Bioinformatics Software and Services Market (by End-User)
Figure 49: Global Single Cell Bioinformatics Software and Services Market (by End- User), $Million, 2020 and 2031
Figure 50: Global Single Cell Bioinformatics Software and Services Market (Biopharmaceutical Companies), $Million, 2020-2031
Figure 51: Global Single Cell Bioinformatics Software and Services Market (Research and Academic Institutes), $Million, 2020-2031
Figure 52: Global Single Cell Bioinformatics Software and Services Market (by Others), $Million, 2020-2031
Figure 53: Global Single Cell Bioinformatics Software and Services Market Snapshot (by Region)
Figure 54: Global Single Cell Bioinformatics Software and Services Market (by Region), $Million, 2020-2031
Figure 55: Global Single Cell Bioinformatics Software and Services Market (by Region), 2020 and 2031
Figure 56: North America Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 57: North America Single Cell Bioinformatics Software and Services Market (by Application), $Million, 2020 and 2031
Figure 58: North America Single Cell Bioinformatics Software and Services Market (by Country), $Million, 2020-2031
Figure 59: U.S. Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 60: Canada Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 61: Europe Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 62: Europe Single Cell Bioinformatics Software and Services Market (by Application), $Million, 2020 and 2031
Figure 63: Europe Single Cell Bioinformatics Software and Services Market (by Country), $Million, 2020–2031
Figure 64: Germany Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 65: France Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 66: U.K. Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 67: Italy Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 68: Spain Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 69: Rest-of-Europe Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 70: Asia-Pacific Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 71: Asia-Pacific Single Cell Bioinformatics Software and Services Market (by Application), $Million, 2020 and 2031
Figure 72: Asia-Pacific Single Cell Bioinformatics Software and Services Market (by Country), $Million, 2020-2031
Figure 73: Japan Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 74: China Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 75: Australia Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 76: India Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 77: South Korea Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 78: Rest-of-Asia-Pacific Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 79: Latin America Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 80: Latin America Single Cell Bioinformatics Software and Services Market (by Application), $Million, 2020 and 2031
Figure 81: Latin America Single Cell Bioinformatics Software and Services Market (by Country), $Million, 2020-2031
Figure 82: Brazil Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 83: Mexico Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 84: Rest-of-Latin America Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 85: Rest-of-the-World World Single Cell Bioinformatics Software and Services Market (by Application), $Million, 2020 and 2031
Figure 86: Rest-of-the-World Single Cell Bioinformatics Software and Services Market, $Million, 2020-2031
Figure 87: Total Number of Companies Profiled
Figure 88: Global Single Cell Bioinformatics Software and Services Market: Value Chain
Figure 89: Illumina, Inc.: Products & Services Portfolio
Figure 90: Illumina, Inc.: Overall Financials, $Million, 2020-2022
Figure 91: Illumina, Inc.: Revenue (by Business Segment), $Million, 2019-2021
Figure 92: Illumina, Inc.: Revenue (by Region), $Million, 2019-2021
Figure 93: Illumina, Inc.: R&D Expenditure, $Million, 2019-2022
Figure 94: Illumina, Inc.: SWOT Analysis
Figure 95: QIAGEN N.V.: Products Portfolio
Figure 96: QIAGEN N.V.: Overall Financials, $Million, 2018-2020
Figure 97: QIAGEN N.V.: Revenue (by Business Segment), $Million, 2018–2020
Figure 98: QIAGEN N.V.: Revenue (by Region), $Million, 2018-2020
Figure 99: QIAGEN N.V.: R&D Expenditure, $Million, 2018-2020
Figure 100: QIAGEN N.V.: SWOT Analysis
Figure 101: BD.: Product Portfolio
Figure 102: BD.: Overall Financials, $Million, 2019-2021
Figure 103: BD.: Revenue (by Business Segment), $Million, 2018–2020
Figure 104: BD.: Revenue (by Region), $Million, 2018-2020
Figure 105: BD.: R&D Expenditure, $Million, 2018-2020
Figure 106: BD.: SWOT Analysis
Figure 107: PacBio: Product Portfolio
Figure 108: PacBio: Overall Financials, $Million, 2018-2020
Figure 109: PacBio: Revenue (by Business Segment), $Million, 2018–2020
Figure 110: PacBio: Revenue (by Region), $Million, 2018-2020
Figure 111: PacBio: R&D Expenditure, $Million, 2018-2020
Figure 112: PacBio: SWOT Analysis
Figure 113: Fluidigm Corporation: Product Portfolio
Figure 114: Fluidigm Corporation: Overall Financials, $Million, 2018-2020
Figure 115: Fluidigm Corporation: Revenue (by Business Segment), $Million, 2018–2020
Figure 116: Fluidigm Corporation: Revenue (by Region), $Million, 2018-2020
Figure 117: Fluidigm Corporation: R&D Expenditure, $Million, 2018-2020
Figure 118: Fluidigm Corporation: SWOT Analysis
Figure 119: NanoString: Product Portfolio
Figure 120: NanoString: Overall Financials, $Million, 2018-2020
Figure 121: NanoString: Revenue (by Business Segment), $Million, 2018–2020
Figure 122: NanoString: Revenue (by Region), $Million, 2018-2021
Figure 123: NanoString: R&D Expenditure, $Million, 2018-2020
Figure 124: NanoString: SWOT Analysis
Figure 125: Takara Bio Inc.:Product Portfolio
Figure 126: Takara Bio Inc.: Overall Financials, $Million, 2019-2021
Figure 127: Takara Bio Inc.: Revenue (by Business Segment), $Million, 2019–2021
Figure 128: Takara Bio Inc.: Revenue (by Region), $Million, 2019-2021
Figure 129: Takara Bio Inc.: R&D Expenditure, $Million, 2019-2021
Figure 130: Takara Bio Inc.: SWOT Analysis
Figure 131: BGI: Product Portfolio
Figure 132: BGI: SWOT Analysis
Figure 133: Oxford Nanopore Technologies, plc.: Product Portfolio
Figure 134: Oxford Nanopore Technologies plc.: Overall Financials, $Million, 2018-2020
Figure 135: Oxford Nanopore Technologies plc.: Revenue (by Business Segment), $Million, 2018–2020
Figure 136: Oxford Nanopore Technologies plc.: Revenue (by Region), $Million, 2019-2021
Figure 137: Oxford Nanopore Technologies plc.: R&D Expenditure, $Million, 2020-2021
Figure 138: Oxford Nanopore Technologies plc.: SWOT Analysis
Figure 139: Partek, Incorporated: Product Portfolio
Figure 140: Partek, Incorporated: SWOT Analysis
Figure 141: Akoya Biosciences, Inc.: Product Portfolio
Figure 142: Akoya Biosciences, Inc.: SWOT Analysis
Figure 143: IsoPlexis: Product Portfolio
Figure 144: IsoPlexis SWOT Analysis
Figure 145: Scipio Biosciences: Product Portfolio
Figure 146: Scailyte: Product Portfolio
Figure 147: BioBam Spain: Product Portfolio
List of Tables
Table 1: Likert Scale
Table 2: Impact Analysis of Market Drivers
Table 3: Impact Analysis of Market Restraints
Table 4: Bioinformatics Sequence Analysis Software Offered by Key Players
Table 5: Biopharmaceutical Companies and Providers
Table 6: Research and Academic Institutes and Providers
Table 7: North America: Market Dynamics
Table 8: Europe: Market Dynamics
Table 9: Asia-Pacific: Market Dynamics
Table 10: Latin America: Market Dynamics